Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.19
+1.32 (4.91%)
At close: Feb 24, 2026, 4:00 PM EST
28.75
+0.56 (1.99%)
After-hours: Feb 24, 2026, 7:38 PM EST
HRMY Market Cap
HRMY has a market cap or net worth of $1.62 billion as of February 24, 2026. Its market cap has decreased by -23.98% in one year.
Market Cap
1.62B
Enterprise Value
1.01B
1-Year Change
-23.98%
Ranking
Category
Stock Price
$28.19
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.62B, an increase of 252.17%. That is a compound annual growth rate of 25.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 1.62B | -24.67% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.70B |
| Enliven Therapeutics | 1.68B |
| Sionna Therapeutics | 1.67B |
| Celldex Therapeutics | 1.65B |
| Nurix Therapeutics | 1.65B |
| Veradermics | 1.64B |
| Ardelyx | 1.61B |
| Relay Therapeutics | 1.59B |